We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RCEL market cap is 224.04M. The company's latest EPS is USD -2.3464 and P/E is -3.65.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.25M | 11.1M | 15.2M | 19.55M | 18.41M |
| Operating Income | -12.27M | -17.21M | -15.62M | -13.81M | -9.96M |
| Net Income | -7.07M | -18.66M | -15.39M | -16.21M | -11.59M |
| Year End 31 December 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31.29M | 13.96M | 37.64M | 51.57M | 64.25M |
| Operating Income | -26.31M | -15M | -27.51M | -42.66M | -56.59M |
| Net Income | -26.58M | -14.96M | -26.67M | -35.38M | -61.85M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 111.64M | 97.38M | 87.83M | 81.05M | 79.71M |
| Total Liabilities | 61.89M | 64.81M | 63.51M | 68.6M | 74.97M |
| Total Equity | 49.06M | 32.57M | 23.92M | 12.23M | 4.5M |
| Year End 31 December 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 125.5M | 116.02M | 98.26M | 111.64M | 79.71M |
| Total Liabilities | 9.85M | 11.39M | 13.52M | 61.89M | 74.97M |
| Total Equity | 115.66M | 104.62M | 84.74M | 49.06M | 4.5M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.01M | -20.86M | -33.64M | -40.86M | -48.94M |
| Investing | 1.61M | 15.07M | 27.5M | 34.89M | 37.36M |
| Financing | 40.37M | 631k | 1.48M | 2.49M | 3.51M |
| Year End 31 December 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.9M | -5.5M | -19.09M | -38.01M | -48.94M |
| Investing | -1.17M | -49.68M | -19.33M | 1.61M | 37.36M |
| Financing | 64.05M | 7k | 900k | 40.37M | 3.51M |
| Market Cap | 224.04M |
| Price to Earnings Ratio | -3.65 |
| Price to Sales Ratio | 3.51 |
| Price to Cash Ratio | 16.06 |
| Price to Book Ratio | 47.57 |
| Dividend Yield | - |
| Shares Outstanding | 26.36M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.47 (5.37%) |
| Company Name | Avita Medical Inc |
| Address |
3411 silverside road tatnall building wilmington, delaware 19810 |
| Website | https://www.avitamedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
